|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus显示文摘 | Alexander J. Thompson Andrew J. Muir Mark S. Sulkowski Dongliang Ge Jacques Fellay Kevin V. Shianna Thomas Urban Nezam H. Afdhal Ira M. Jacobson Rafael Esteban Fred Poordad Eric J. Lawitz Jonathan McCone Mitchell L. Shiffman Greg W. Galler William M. Lee | 2010 | Gastroenterology2010，，1： | 7 |
| 2 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘 | Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford | 2010 | The Lancet2010，，9742： | 3 |
| 3 | Boceprevir for Chronic HCV Genotype 1 Infection in Patients with Prior Treatment Failure to Peginterferon/Ribavirin, including Prior Null Response显示文摘 | John M. Vierling Mitchell Davis Steven Flamm Stuart C. Gordon Eric Lawitz Eric M. Yoshida Joseph Galati Velimir Luketic Jonathan McCone Ira Jacobson Patrick Marcellin Andrew J. Muir Fred Poordad Lisa D. Pedicone Janice Albrecht Clifford Brass Anita Y.M. H | 2013 | Journal of Hepatology2013，，： | 2 |
| 4 | Boceprevir for untreated chronic HCV genotype 1 infection显示文摘 | Poo~ad F Bacon BR | 2011 | N Engl J Med2011，364，13： | 1 |
| 5 | Drained shear strength parameters for analysis of landslides显示文摘 | Stark T D Choi H McCone S | 2005 | Journal of Geotechnical and Geoenvironmental Engineering2005，131，5： | 1 |
| 6 | Boceprevir for untreated chronic HCV genotype 1 infection 显示文摘 | Poordad F McCone J Jr Bacon BR | 2011 | N Engl J Med2011，364，13： | 1 |
| 7 | Boceprevir for untreated chronic HCV genotype 1 infection显示文摘 | Poordad F Mccone JJr Bacon BR | 2011 | N Engl J Med2011，364，13： | 1 |
| 8 | HCV SPRINT-1 final results: SVR 24 from a phase 2 study of boceprevir plus PeglFN alpha-2b/ribavirin in treatment-naive subjects with genotype 1 chronic hepatitis显示文摘 | Kwo P Lawitz E J McCone J | 2009 | J Hepatol2009，50，1： | 1 |
| 9 | Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection 显示文摘 | McHutchison JG Lawitz FJ Shiffman ML Muir AJ Galler GW McCone J Nyberg LM Lee WM Ghalib RH Schiff ER Galati JS Bacon BR Davis MN Mukhopadhyay P Koury K Noviello S Pedicone LD Brass CA Albrecht JK Sulkowski MS IDEAL Study Team | 2009 | N Engl J Med2009，361，6： | 1 |
| 10 | Boeeprevir for untreated chronic HCV genotype 1 infection显示文摘 | Poordad F McCone Jr J Bacon B R et d | 2011 | N EnglJ Ned2011，364，11： | 1 |
| 11 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘 | Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford | 2010 | The Lancet2010，，9742： | 1 |
| 12 | Drained shear strength parameters for analysis of landslides 显示文摘 | Stark T D Choi H McCone S | 2005 | Journal of Geotechnical and Geoenvironmental Engineering2005，131，5： | 1 |
| 13 | Boceprevlr for Untreated Chronic HCV Genotype 1 Infection显示文摘 | Poordad F McCone J Jr Bacon BR | | New England Journal of Medicine0，，： | 1 |
| 14 | HCV SPRINT-1 final results:SVR 24 from a phase 2 study of boceprevir plus Peglntron? (peginterferon alfa-2b)/ribavirin in treatment-naive subjects with genotype 1 chronic hepatitis C显示文摘 | Kwo P Lawitz E McCone J | | Journal of Hepatology0，，： | 1 |
| 15 | Boceprevir for untreated chronic HCV genotype 1 infection 显示文摘 | Poordad F McCone J Jr Bacon BR Bruno S Manns MP Sulkowski MS Jacobson IM Reddy KR Goodman ZD Boparai N DiNubile MJ Sniukiene V Brass CA Albrecht JK Bronowicki JP SPRINT-2 Investigators | 2011 | N Engl J Med2011，364，13： | 1 |
| 16 | Interim results from HCV SPRINT-1:RVR/EVR from phase 2 study of boceprovir plus pegintron (peginteferon alfa-2b)/ribavirin in treatment-naive subjects with HCV genotype 1 CHC显示文摘 | Kwo P Lawitz E McCone J | 2008 | J Hepatol2008，48，2： | 1 |
| 17 | Impact of weight -based ribavirin with peginteferon alfa -2b in African Americans with hepatitis C virus genotype 1 显示文摘 | Jacobson IM Brown RS Jr McCone J | 2007 | Hepatology2007，46，4： | 1 |
| 18 | Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial显示文摘 | Paul Y Kwo Eric J Lawitz Jonathan McCone Eugene R Schiff John M Vierling David Pound Mitchell N Davis Joseph S Galati Stuart C Gordon Natarajan Ravendhran Lorenzo Rossaro Frank H Anderson Ira M Jacobson Raymond Rubin Kenneth Koury Lisa D Pedicone Clifford | 2010 | The Lancet2010，，9742： | 1 |
| 19 | Boceprevir for untreated chronic HCV genotype 1 infection 显示文摘 | Poordad F McCone J Jr Bacon BR | 2011 | N Engl J Med2011，364，13： | 1 |
| 20 | Boceprevir for untreated chronic HCV genotype 1 infection 显示文摘 | Poordad F Mccone J Jr Bacon BR | 2011 | N Engl J Med2011，364，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员